BioXcel Therapeutics, Inc. - AI-Enhanced Message Board
Seneste diskussioner
What is the market opportunity for BioXcel in the estimated 23 million annual at-home agitation episodes lacking FDA-approved treatments?
How might current high interest rates impact BTAI's ability to fund its debt maturities in 2026 and 2027?
How does the new 57-77 million annual agitation episodes estimate impact IGALMI®'s market potential? AI+
How does the new 57-77 million annual agitation episodes estimate impact IGALMI®'s market potential?
How does the new 57-77 million annual agitation episodes estimate impact IGALMI®'s market potential? AI+
How does the new 57-77 million annual agitation episodes estimate impact IGALMI®'s market potential?
How does the new 57-77 million annual agitation episodes estimate impact IGALMI®'s market potential? AI+
How does the new 57-77 million annual agitation episodes estimate impact IGALMI®'s market potential?
How does the new 57-77 million annual agitation episodes estimate impact IGALMI®'s market potential? AI+
How does the new 57-77 million annual agitation episodes estimate impact IGALMI®'s market potential?
How will BioXcel address its $37.32 million cash balance against a $43.4 million 9-month operating cash burn?
What is the strategic significance of Qatar Investment Authority and Oaktree Capital's 5.20% ownership reported on December 18, 2024?
What factors drove the 829.33% increase in institutional shares of BTAI in the most recent quarter? AI+
What factors drove the 829.33% increase in institutional shares of BTAI in the most recent quarter?
Why did the stock valuation go down
What is the strategic rationale for pausing BXCL701 immuno-oncology development, as stated in the Q3 2025 10-Q?
What specific factors drove the 153.33% increase in institutional owners for BTAI in the most recent quarter?
Why did BTAI's Q2 2025 IGALMI® net revenue drop to $120K from $1.1M in Q2 2024?
What was the total value of insider stock sales in BTAI since January 2025?
Why did Oramed Pharmaceuticals acquire 2M BTAI shares on March 4, 2025, and more through September 2025?
What specific details in the May 12, 2025, Q1 filing explain the significant drop in IGALMI® revenue?
What caused the 829.33% increase in institutional long shares MRQ despite BTAI's 77.30% share price decline by August 2025?
Why did BTAI's average price target decrease to $9 on July 17, 2025, after being $17.75 in June? AI+
Why did BTAI's average price target decrease to $9 on July 17, 2025, after being $17.75 in June?
Why has no significant insider buying or selling for BTAI been reported in 2024-2025 despite share price decline?
Why did the average one-year price target for BTAI fluctuate from $52.36 in February to $9 in July 2025?
What caused the 1Q 2025 IGALMI® revenue decline to $168,000 from $582,000 in 1Q 2024?
Why has there been no significant insider buying activity reported despite BTAI's 77.30% price decline since August 2024?
Why do analysts project BTAI's 2025 annual revenue at $495MM, contrasting with Q2 2025's $0.12MM product revenue?
